mortality
patients
patient
svr
populations
c population
liver
livers
related
relative
risk
causes
caused
cause
modifiable
modify
treatment
death
deaths
behaviors
use
percent
cancer
healthmap
relatively high number given
lifestyle
cancers diseases
team
drug
http
live
living
noted
noting
affect
cdc
h
opportune
j
hepatitis
disease
experienced
ci
completing
completion
complete
ifn antiviral
smr
individuals
large
p
response
point
points
began
characteristics
study
